One of the largest problems with cancer treatment is the development of resistance to anticancer therapies. A research team has found that a commonly used chemotherapy drug may be repurposed as a treatment for resurgent or chemotherapy-resistant leukemia. The researchers developed a nanoparticle that allowed doxorubicin, a commonly used chemotherapy drug, to be injected safely and released sustainably over time. Because of its rate of drug release, the patented nanoparticle was more effective than both a solution of the pure drug and the only commercially available version of a nanoparticle carrying doxorubicin.
An official website of the United States government.